Calumet Specialty Products
CLMT
117 hedge funds and large institutions have $256M invested in Calumet Specialty Products in 2015 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 48 increasing their positions, 23 reducing their positions, and 18 closing their positions.
109% more call options, than puts
Call options by funds: $11.1M | Put options by funds: $5.28M
109% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 23
0% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 18
1% less funds holding
Funds holding: 118 → 117 (-1)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
57% less capital invested
Capital invested by funds: $598M → $256M (-$342M)
Top Buyers
| 1 |
Barclays
London,
United Kingdom
|
+$16.9M |
| 2 |
SCA
Salient Capital Advisors
Houston,
Texas
|
+$10.3M |
| 3 |
Morgan Stanley
New York
|
+$5.41M |
| 4 |
SOAMC
Spirit of America Management Corp
Syosset,
New York
|
+$5.13M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3.83M |
Top Sellers
CLMT Hedge Fund Activity: Q1 2015 in Review
117 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Calumet Specialty Products (CLMT) for Q1 2015, worth a combined $256M — down 57% from $598M a quarter earlier.
Fund positioning in CLMT was balanced in Q1 2015: 18 funds opened new positions, 18 closed out, 48 added to existing stakes and 23 trimmed.
The largest buyer was Barclays, adding an estimated $16.9M. The largest seller was Americafirst Capital Management, exiting entirely with an estimated $371M sold.
- 117 institutional investors held Calumet Specialty Products (CLMT) as of Q1 2015, down from 118 in Q4 2014.
- Funds reported $256M of Calumet Specialty Products stock for Q1 2015, down 57% quarter-over-quarter.
- 18 funds opened new Calumet Specialty Products positions in Q1 2015 and 18 closed out, a net change of 0 holders.
- The largest Calumet Specialty Products buyer in Q1 2015 was Barclays, an estimated $16.9M added.
- The largest Calumet Specialty Products seller in Q1 2015 was Americafirst Capital Management, an estimated $371M sold.
Based on aggregated 13F filings for Q1 2015.